Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-15

FDA Approved: TESTOSTERONE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for testosterone submitted by Actavis Pharma, Inc., authorizing changes to the product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

SUPPL AP for TESTOSTERONE (TESTOSTERONE)